Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure-Reference-Cited by-同舟云学术

Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure

Published:2020-09 Issue: Volume:18 Page:738-750
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Nicolas Clara T.,Kaiser Robert A.,Hickey Raymond D.,Allen Kari L.,Du Zeji,VanLith Caitlin J.,Guthman Rebekah M.,Amiot Bruce,Suksanpaisan Lukkana,Han Bing,Francipane Maria Giovanna,Cheikhi Amin,Jiang Huailei,Bansal Aditya,Pandey Mukesh K.,Garg Ishan,Lowe Val,Bhagwate Aditya,O’Brien Daniel,Kocher Jean-Pierre A.,DeGrado Timothy R.,Nyberg Scott L.,Lagasse Eric,Lillegard Joseph B.^ORCID

Funder

Children's Hospitals and Clinics of Minnesota

Mayo Clinic

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Organ shortage: the greatest challenge facing transplant medicine;Shafran;World J. Surg.,2014

2. Host conditioning and rejection monitoring in hepatocyte transplantation in humans;Soltys;J. Hepatol.,2017

3. Liver cirrhosis;Schuppan;Lancet,2008

4. On the enzymic defects in hereditary tyrosinemia;Lindblad;Proc. Natl. Acad. Sci. USA,1977

5. Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function;Bartlett;J. Inherit. Metab. Dis.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embryos assist morphogenesis of others through calcium and ATP signaling mechanisms in collective teratogen resistance;Nature Communications;2024-01-17

2. Future medicine: from molecular pathways to the collective intelligence of the body;Trends in Molecular Medicine;2023-09

3. Cell therapy in end-stage liver disease: replace and remodel;Stem Cell Research & Therapy;2023-05-25

4. Cell and cell-derivative-based therapy for liver diseases: current approaches and future promises;Expert Review of Gastroenterology & Hepatology;2023-02-02

5. mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model;Molecular Therapy - Methods & Clinical Development;2022-09